ADSL and keratitis: In contrast, it showed efficient inhibition of keratitis caused by C. albicans infection in mice (Figure 10E).[128] The development of AMPs is ongoing and has shown encouraging results in the treatment of eye infections.[119, 129] Future research should focus on ways to reduce the development of drug resistance while adding a combination of in vitro and in vivo assessments.